Russell J. Cox
CIK 1512984 · Chief Executive Officer · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$23.32M
Companies
3
Total Filings
55
Lifetime Open-Market Net
-$3.23M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 3 of 6
55 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-03-08 | JAZZ | Tax (F) | −1,793 | -$238.1K | EDGAR |
| 2017-03-06 | JAZZ | Grant (A) | +10,000 | $0 | EDGAR |
| 2017-03-01 | JAZZ | Tax (F) | −2,507 | -$343.4K | EDGAR |
| 2017-01-19 | JAZZ | Sell (S) | −4,000 | -$515.0K | EDGAR |
| 2016-08-10 | JAZZ | Mixed | −9,543 | -$1.43M | EDGAR |
| 2016-05-19 | Spyre Therapeutics, Inc. (AGLE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-04-13 | JAZZ | Sell (S) | −4,000 | -$547.9K | EDGAR |
| 2016-04-12 | Spyre Therapeutics, Inc. (AGLE) Delisted | Buy (P) | +7,000 | $70.0K | EDGAR |
| 2016-03-09 | JAZZ | Tax (F) | −1,550 | -$198.2K | EDGAR |
| 2016-03-02 | JAZZ | Tax (F) | −939 | -$114.2K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.